REQUEST A DEMO
Total
USD $0.00
Search more companies

Sri Sai Uma Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sri Sai Uma Laboratories Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sri Sai Uma Laboratories Private Limited is an enterprise based in India. Its main office is in Hyderabad. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on August 20, 2010. From the latest financial highlights, Sri Sai Uma Laboratories Private Limited reported a net sales revenue increase of 9.48% in 2024. Its total assets grew by 33.8% over the same period.

Legal Address
Flat No.C1409, Bhavyas Tulasivanam, Navodaya Colony, Kukatpally
Hyderabad; Telangana; Postal Code: 500072

Contact Details: Purchase the Sri Sai Uma Laboratories Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sri Sai Uma Laboratories Private Limited report to view the information.
Financial Auditors:
Purchase the Sri Sai Uma Laboratories Private Limited report to view the information.
Incorporation Date:
August 20, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sri Sai Uma Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.48%
Total Operating Revenue
9.27%
Operating Profit
-86.47%
EBITDA
-62.25%
Net Profit/Loss for the Period
N/A
Total Assets
33.8%
Total Equity
-3.76%
Operating Profit Margin
-4.63%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
75.58%
Quick Ratio
0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?